Navigation Links
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Date:9/17/2011

ster, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (Media)
Arvind Sood, 805-447-1060 (Investors)

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

(1)  "Facts and statistics about osteoporosis and its impact." International
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
2. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
3. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
4. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
5. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
6. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
7. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
8. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
9. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, ... EURONEXT: SAN) and the life sciences team at Google ... and outcomes for people with type 1 and type ... and devices with Google,s expertise in analytics, miniaturized electronics ... how to improve diabetes care by developing new tools ...
(Date:8/31/2015)...  AMRI (NASDAQ: AMRI ) and Saneca ... on the development, manufacture and marketing of a ... collaboration combines Saneca,s strength in extracting opiates from ... manufacturing controlled substance APIs with AMRI,s U.S. assets ... these facilities. The collaboration will also capitalize on ...
(Date:8/31/2015)... Vascular Ltd., together with its subsidiaries (the "Company" ... the "Group"), a global company engaged in the ... for the minimally invasive treatment of vascular disease, ... ("BTK") cohort of patients in the Chocolate® Balloon ... 15, 2015 at the 5th Annual Amputation Prevention ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... Communicating effectively oftentimes goes beyond words. Facial expressions ... joy, excitement, or even acceptance and approval through ... discolored and uneven teeth hold you back from ... allows dentists to help patients increase their communication ...
... DIEGO, Aug. 3, 2011 Proacta Incorporated and ... the expansion of their Collaborative Research, Development and ... a hypoxia-activated pro-drug for the treatment of cancer. ... parties agreed to expand their existing collaboration to ...
Cached Medicine Technology:A Beautiful Smile Enhances Communication Skills 2Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement 2Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement 3
(Date:8/31/2015)... ... August 31, 2015 , ... ITC Global Translations website, ... for specific translation services within the medical and pharmaceutical industries. These are industries ... successful work. , ITC Global Translations specializes in professional translation services for materials ...
(Date:8/31/2015)... Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... 16 by CDA Press, the expert guest author addressed the topic of treating back ... author explained that, while steroids were shown to slightly improve physical function in patients ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence in Wellness, ... to the Lake Orion area. This program is one of the most successful ... management program will incorporate group fitness and nutritional consultations to help people lose ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about getting a hair transplant ... learning more about the procedure beyond the information found on the Internet can attend ... surgeon Parsa Mohebi will be on hand to answer patients hair transplant questions at ...
(Date:8/31/2015)... , ... August 31, 2015 , ... In an ... the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of 3-D ... discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools could ...
Breaking Medicine News(10 mins):Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
... Indian Systems of Medicine and the government was now preparing a ... , state Health Minister K K S S R Ramachandran, said ... an Ayurveda college and would take all efforts in this direction, ... the All India Ayurvedic Congress (AIAC) as part of its centenary., ...
... ever-private fertility clinic has been established by two leading ... around the ages of 45 with the// treatment. ... and a leading authority in the field of IVF, ... is qualified to carry out pre-implantation genetic diagnosis that ...
... has yet again been honored with the Magnet status, ... to be the highest recognition for nursing services signifying ... second time that Rush University has received this much-coveted ... the United States have received Magnet designation twice. ...
... Jackson and Fran Walsh’s donation of $500,000 to the University ... well in their home// country. Citing that stem cell research ... hoped the donation could be put to good use. ... Parkinson's disease, and the level of personal suffering inflicted on ...
... babies born in the United States are screened for ... the March of Dimes and the American Academy of ... of Medical Genetics calling for expanded screening for 29 ... and child health expert Russell Kirby, Ph.D., agrees. “All ...
... are taking due precaution following reports of suspected dengue ... with the blood sample// of the affected being sent ... has shown symptoms of Dengue fever and we have ... awaiting the reports," KDMC run Municipal hospital doctor Sanjeev ...
Cached Medicine News:Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 2Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 3Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 4Health News:Rush of honor for Rush University – Magnet Status for Excellence in Nursin 2
... 300A is a portable, digital A-scan system ... combination of a high frequency, low noise ... capture immediately upon application of the probe ... provides: live A-scan display, storage of 5 ...
... Echoscan US-800 Ultrasonic A-Scan offers ... compact, portable package. Besides,its compact ... highly accurate measurement and easy ... automatic freezing and manual gate.,NIDEK ...
... first very high frequency digital ultrasound eye ... provides microscopic resolution images and precision measurement ... of the human eye. Artemis is a ... In use, the patient leans forward placing ...
ISYSTEM-ABDv2™A/B Scan unit. True Geometry With Stepped Zoom, Pan, Freeze Frame, Post Image Processing....
Medicine Products: